Detalhe da pesquisa
1.
Fasting-mimicking diet and hormone therapy induce breast cancer regression.
Nature
; 583(7817): 620-624, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32669709
2.
Apoptosis reprogramming triggered by splicing inhibitors sensitizes multiple myeloma cells to Venetoclax treatment.
Haematologica
; 107(6): 1410-1426, 2022 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34670358
3.
Author Correction: Fasting-mimicking diet and hormone therapy induce breast cancer regression.
Nature
; 588(7839): E33, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33273708
4.
Transcriptome analysis defines myocardium gene signatures in children with ToF and ASD and reveals disease-specific molecular reprogramming in response to surgery with cardiopulmonary bypass.
J Transl Med
; 18(1): 21, 2020 01 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31924244
5.
SIRT6 deacetylase activity regulates NAMPT activity and NAD(P)(H) pools in cancer cells.
FASEB J
; 33(3): 3704-3717, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30514106
6.
SIRT6 inhibitors with salicylate-like structure show immunosuppressive and chemosensitizing effects.
Bioorg Med Chem
; 25(20): 5849-5858, 2017 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28958848
7.
Use of Attribute Driven Incremental Discretization and Logic Learning Machine to build a prognostic classifier for neuroblastoma patients.
BMC Bioinformatics
; 15 Suppl 5: S4, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25078098
8.
Cyclic fasting bolsters cholesterol biosynthesis inhibitors' anticancer activity.
Nat Commun
; 14(1): 6951, 2023 10 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37907500
9.
CD38-Induced Metabolic Dysfunction Primes Multiple Myeloma Cells for NAD+-Lowering Agents.
Antioxidants (Basel)
; 12(2)2023 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36830052
10.
SIRT6 enhances oxidative phosphorylation in breast cancer and promotes mammary tumorigenesis in mice.
Cancer Metab
; 9(1): 6, 2021 Jan 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-33482921
11.
Safety and Feasibility of Fasting-Mimicking Diet and Effects on Nutritional Status and Circulating Metabolic and Inflammatory Factors in Cancer Patients Undergoing Active Treatment.
Cancers (Basel)
; 13(16)2021 Aug 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34439167
12.
Amino acid depletion triggered by Ê-asparaginase sensitizes MM cells to carfilzomib by inducing mitochondria ROS-mediated cell death.
Blood Adv
; 4(18): 4312-4326, 2020 09 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-32915979
13.
Targeting the deacetylase SIRT6 unveils spliceosome deregulation as exploitable vulnerability for aggressive myeloma.
Blood Adv
; 7(14): 3472-3478, 2023 07 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-36897214
14.
Author Correction: Cyclic fasting bolsters cholesterol biosynthesis inhibitors' anticancer activity.
Nat Commun
; 14(1): 7614, 2023 Nov 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37993421
15.
Mesenchymal Stem Cell-Derived Extracellular Vesicles as Mediators of Anti-Inflammatory Effects: Endorsement of Macrophage Polarization.
Stem Cells Transl Med
; 6(3): 1018-1028, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28186708
16.
First Characterization of Human Amniotic Fluid Stem Cell Extracellular Vesicles as a Powerful Paracrine Tool Endowed with Regenerative Potential.
Stem Cells Transl Med
; 6(5): 1340-1355, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28271621
17.
Nicotinic Acid Phosphoribosyltransferase Regulates Cancer Cell Metabolism, Susceptibility to NAMPT Inhibitors, and DNA Repair.
Cancer Res
; 77(14): 3857-3869, 2017 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28507103
18.
Novel phage display-derived neuroblastoma-targeting peptides potentiate the effect of drug nanocarriers in preclinical settings.
J Control Release
; 170(2): 233-41, 2013 Sep 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-23714122
19.
The use of the orthotopic model to validate antivascular therapies for cancer.
Int J Dev Biol
; 55(4-5): 547-55, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21858775
20.
Tumor regression and curability of preclinical neuroblastoma models by PEGylated SN38 (EZN-2208), a novel topoisomerase I inhibitor.
Clin Cancer Res
; 16(19): 4809-21, 2010 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20702613